IMCC - Mergers and acquisitions

TORONTO and GLIL YAM, Israel, Jan. 17, 2023 /CNW/ -- Rafael Gabay (the "Acquiror"), a 10% holder of common shares of IM Cannabis Corp. ("IMCC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), announces that he has acquired an aggregate of 303,295 common shares in the capital of the Company ("Common Shares") and 303,295 Warrants (as hereinafter defined) pursuant to a non-brokered private placement offering of units ("Units") of the Company (the "Offering").  On January 16, 2023, the Acquiror acquired an aggregate of 303,295 Units pursuant to the Offering (the "Acquisition"). Each Unit was acquired for US$1.25 for aggregate consideration of US$379,118.75. Each Unit consisted of one Common Share and

TORONTO and GLIL YAM, Israel, Jan. 17, 2023 /CNW/ -- Oren Shuster (the "Acquiror"), CEO, director and founder of IM Cannabis Corp. ("IMCC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), announces that he has acquired an aggregate of 856,704 common shares in the capital of the Company ("Common Shares") and 856,704 Warrants (as hereinafter defined) pursuant to a non-brokered private placement offering of units ("Units") of the Company (the "Offering").   On January 16, 2023, the Acquiror acquired an aggregate of 856,704 Units pursuant to the Offering (the "Acquisition"). Each Unit was acquired for US$1.25 for aggregate consideration of US$1,070,880. Each Unit consisted of one Common Share and one

TORONTO and GLIL YAM, Israel, Jan. 17, 2023 /CNW/ -- Rafael Gabay (the "Acquiror"), CEO, director and founder of IM Cannabis Corp. ("IMCC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), announces that he has acquired an aggregate of 303,295 common shares in the capital of the Company ("Common Shares") and 303,295 Warrants (as hereinafter defined) pursuant to a non-brokered private placement offering of units ("Units") of the Company (the "Offering"). On January 16, 2023, the Acquiror acquired an aggregate of 303,295 Units pursuant to the Offering (the "Acquisition"). Each Unit was acquired for US$1.25 for aggregate consideration of US$379,118.75. Each Unit consisted of one Common Share and one

TORONTO and GLIL YAM, Israel, Sept. 8, 2022 /PRNewswire/ -- Rafael Gabay, a promoter and significant shareholder of IM Cannabis Corp. ("IMCC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), announces that he has acquired an aggregate of 613,496 common shares in the capital of IMCC (the "Common Shares") as part of IMCC's non-brokered private placement of 4,887,496 Common Shares at a price of USD$0.50 per Common Share for aggregate proceeds of USD$2,443,748 (the "Private Placement"). Mr. Gabay paid aggregate cash consideration of USD$306,000 ($397,279.80 based on the Bank of Canada daily average exchange rate on August 24, 2022). Immediately prior to the Private Placement, Mr. Gabay held beneficia

TORONTO and GLIL YAM, Israel, April 12, 2022 /PRNewswire/ -- Oren Shuster, CEO, director and founder of IM Cannabis Corp. ("IMCC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), announces that he has acquired an aggregate of 150,000 common shares in the capital of IMCC (the "Common Shares") in a series of open market transactions between April 5 and 8, 2022 through the facilities of the Nasdaq Capital Market (the "NASDAQ") (the "Acquisition"). Mr. Shuster acquired the Common Shares at an average price of US$2.238 per Common Share (approximately CAD$2.804) for an aggregate purchase price of US$335,731.60 (approximately CAD$420,709.42).     Immediately prior to the Acquisition, Mr. Shuster held be

TORONTO and GLIL YAM, Israel, March 15, 2022 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC) (NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, has completed three strategic acquisitions announced in 2021. The acquisitions were completed through IMC Holdings Ltd. ("IMC Holdings"), a wholly-owned subsidiary of IM Cannabis Corp. and I.M.C Pharma Ltd. ("IMC Pharma"), IMC Holdings' wholly-owned subsidiary, following receipt of all requisite approvals, including from the Israeli Medical Cannabis Unit ("IMCU"). "Each of these strategic acquisitions are key progress points for our Israeli and glo

Strategically located, best in class retailer with approximately CAD$8 million in annualized revenuePurchase price of CAD$4.6 millionTORONTO, ON, GLIL YAM and NATANYA, ISRAEL / ACCESSWIRE / July 28, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the acquisition of the outstanding ordinary shares of R.A. Yarok Pharm Ltd. ("Pharm Yarok"), Rosen High Way Ltd. ("Rosen High Way") and High Way Shinua.Ltd. ("HW Shinua") by IMC Holdings Ltd. ("IMC Holdings"), a wholly-owned Israeli subsidiary of the Company, accel

With Israel's Fast-Paced E-Commerce Adoption and Cannabis Market's High Growth Rate (Averaging 4 Percent1 per Month), Panaxia's Online Platform to Support Patient Base ExpansionAcquisition Broadens IMC's Patient Offering in Israel, Facilitates Stronger Direct Patient Relationships and Enables the Company to Grow its IMC Brand AwarenessOffers Additional Opportunity to Generate Revenue and Margin on Third-Party Products and is Synergistic with IMC's Premium and Super-Premium Canadian Indoor Production PortfolioAdds Key Storage, Distribution and Delivery Capabilities, Plus Established Call Center to Support Growth as Israeli Market Prepares for Potential Adult-Use Recreational Cannabis Legaliza

Q4 2020: revenues of $4.9 million and gross margin of 57%1; FY 2020: revenues of $15.9 million and gross margin of 55%1.Preliminary unaudited Q1 2021 revenues expected to be in the range of $8.5 - $9.0 million; gross margin expected to be in the range of 50% to 55%.Q2 2021 revenues expected to be in the range of $17 million - $19 million from continued growth in Israel, resumption of product shipments and growth of revenue in Germany, and inclusion of Trichome operations in the Company's financial results TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / April 23, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adul